Ribociclib impurities include synthetic intermediates, process-related compounds, degradation products, and nitrosamine contaminants. These may arise during manufacturing, formulation, or long-term storage. As a CDK4/6 inhibitor used in the treatment of HR-positive, HER2-negative advanced breast cancer, impurity profiling is essential to ensure therapeutic safety, efficacy, and regulatory compliance. All impurity compounds are structurally characterized and qualified under ICH guidelines for toxicological evaluation and analytical validation.
Pharmacopeial and non-pharmacopeial Ribociclib impurity compounds are available in compliance with European Pharmacopoeia (EP) specifications. These standards support analytical method development, impurity profiling, and stability testing. EP traceable materials are supplied with validated analytical data including purity, structural confirmation, and spectral characterization.
Structurally related compounds and synthetic analogs associated with Ribociclib are included for use in impurity identification, toxicological qualification, and regulatory submission. These materials are thoroughly characterized and conform to international standards. Related compounds are used in forced degradation studies, genotoxicity assessments, and impurity threshold evaluations.
Ribociclib impurity reference standards are provided with validated analytical data including purity, NMR, MS, and full Certificates of Analysis. These standards are used in pharmaceutical research, method validation, and GMP-compliant quality control. EP/USP traceable entries are available upon request and are routinely re-tested to ensure consistency and reliability.
![(2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol | 1374639-77-6 | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47124.png)
![1-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine 1-oxide | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47120.png)
![2-((2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methoxy)-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | NA | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47113.png)
![2-((5-((2-Aminoethyl)amino)pyridin-2-yl)amino)-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | 2460738-27-4 | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47101.png)
![2-(7-Cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)-5-(piperazin-1-yl)pyridine 1-oxide | 2069953-39-3 | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47119.png)
![3-(2-((2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methoxy)-4-(cyclopentylamino)pyrimidin-5-yl)prop-2-yn-1-ol | NA | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47114.png)
![4-(4-(6-((7-Cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazin-1-yl)-4-oxobutanoic acid | 3060653-14-4 | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47122.png)
![7-cyclopentyl-2-((3-hydroxy-5-(piperazin-1-yl)pyridin-2-yl)amino)-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | 3027550-95-1 | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47103.png)
![7-cyclopentyl-2-((3,6-dihydroxy-5-(piperazin-1-yl)pyridin-2-yl)amino)-N,N-dimethyl-7H-pyrrolo[2, 3-d]pyrimidine-6-carboxamide | 3027550-94-0 | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47100.png)
![7-cyclopentyl-2-((5-((2-formamidoethyl)amino)pyridin-2-yl)amino)-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | 3027550-96-2 | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47106.png)
![7-cyclopentyl-2-((5-(4-formylpiperazin-1-yl)pyridin-2-yl)amino)-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | 2460732-08-3 | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47105.png)
![7-cyclopentyl-6-(dimethylcarbamoyl)-2-(5-(piperazin-1-yl)pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine 7-oxide | 2514753-27-4 | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47118.png)
![7-cyclopentyl-N-(hydroxymethyl)-N-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-p yrrolo[2,3-d]pyrimidine-6-carboxamide | 2460734-07-8 | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47102.png)
![7-Cyclopentyl-N,N-dimethyl-2-(nitroso(5-(4-nitrosopiperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | NA | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47109.png)
![7-Cyclopentyl-N,N-dimethyl-2-(nitroso(5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | NA | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47108.png)
![Methyl 7-cyclopentyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylate | 3027550-97-3 | Ribociclib](https://synthinkchemicals.com/wp-content/uploads/2025/04/SA47107.png)
Address
Plot No. CP-135, Pimpri-Chinhwad MIDC, Pune-411019, Maharashtra, India.
© 2014-2024 SynThink Research Chemicals. All Rights Reserved.
Register to add the product to RFQ list
Already have an account? Log in here
Don’t have an account? Register here
